PGAM1 and cancer: Likewise, inhibitors of phosphoglycerate mutase 1 (PGAM1) and mutant isocitrate dehydrogenase (IDH), both catalases involved in glycolysis in cancer cells, are considered to be promising candidates as cancer drugs [80].